SNDX | Syndax Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	15.35 - 16.19
52 Week Range	15.03 - 25.34
Beta	0.74
Implied Volatility	49.12%
IV Rank	52.43%
Day's Volume	1,237,122
Average Volume	1,270,531
Shares Outstanding	85,357,700
Market Cap	1,361,455,315
Sector	Healthcare
Industry	Biotechnology
IPO Date	2016-03-02

Valuation
Profitability
Growth
Health
P/E Ratio	-4.38
Forward P/E Ratio	N/A
EPS	-3.64
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	184
Country	USA
Website	SNDX

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.

SNDX's peers: AGIO, COGT, FGEN, HRMY, IDYA, IMTX, KALV, KROS, KURA, LRMR, MDWD, MDXG, MGNX, MRSN, MRUS, PCVX, PGEN, PLRX, PTGX, QURE, RCKT, REPL, ROIV, RYTM, CGEM, RVMD, VRDN, INZY, AVTE, MLYS, STRO, CYTK, DICE, EWTX, KRTX, DYN, SYRS, TSVT, VCEL, VCYT, VRNA, VTYX, XNCR, YMAB, ZNTL, ZYME

*Chart delayed

Analyzing fundamentals for SNDX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is strong. For more detailed analysis please see SNDX Fundamentals page.

Watching at SNDX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SNDX Technicals page.